Annexon
ANNX • NASDAQ
Annexon is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Douglas E. Love, with a market cap of $745.3M.
CEODouglas E. Love
Next Earnings
Upcoming earnings announcement for Annexon
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.34
Earnings History
Past 11 earnings reports for Annexon
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q3 2025 | -$0.37Est: -$0.34 | -8.8% | - | — |  10-Q |
| Aug 14, 2025 | Q2 2025 | -$0.34Est: -$0.36 | +5.6% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.37Est: -$0.29 | -27.6% | - | — | 10-Q |
| Mar 3, 2025 | Q4 2024 | -$0.33Est: -$0.29 | -13.8% | - | — | 10-K |
| Nov 14, 2024 | Q3 2024 | -$0.25Est: -$0.31 | +19.4% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.23Est: -$0.23 | 0.0% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.21Est: -$0.35 | +40.0% | - | — | 10-Q |
| Mar 26, 2024 | Q4 2023 | -$0.36Est: -$0.48 | +25.0% | -Est: - | — | 10-K |
| Nov 13, 2023 | Q3 2023 | -$0.43Est: -$0.50 | +14.0% | - | — | — |
| Aug 7, 2023 | Q2 2023 | -$0.47Est: -$0.54 | +13.0% | - | — | 10-Q |
| May 8, 2023 | Q1 2023 | -$0.52Est: -$0.52 | 0.0% | - | — | — |